13 employees
Limelight is building an industry-leading platform to develop technologies, advanced targets, and leading drug candidates.
2016
$75M
from 1 investors over 1 rounds
Limelight Bio raised $75M on December 5, 2019
Investors: ATP (Apple Tree Partners)